Why is 3B Blackbio falling/rising?

As of 31-Jul, 3B Blackbio DX Ltd's stock price is currently at Rs 1,534.00, reflecting a decrease of Rs 17.0 or 1.1%. Today's price summary indicates that the stock has fallen after three consecutive days of gains, reaching an intraday low of Rs 1,488.45, which represents a decline of 4.03%. The stock's performance over the past week shows a gain of 2.33%, while it has increased by 4.36% over the past month. Despite these short-term gains, the stock has experienced a year-to-date decline of 22.47%. The company has a low debt-to-equity ratio and has shown healthy long-term growth with an annual operating profit increase of 41.02%. However, recent flat results and a very expensive valuation, indicated by a high price-to-book value, may be contributing to investor concerns, leading to the current price drop.
In the broader market context, the stock's recent performance contrasts with the benchmark Sensex, which has declined by 1.22% over the past week and 3.00% over the past month. This suggests that while 3B Blackbio has outperformed the benchmark in the short term, the overall market sentiment may still be affecting investor confidence. Additionally, the significant drop in delivery volume by 72% compared to the five-day average indicates falling investor participation, which could further pressure the stock price. The lack of domestic mutual fund investment, holding only 0% of the company, may also reflect a cautious outlook from institutional investors regarding the stock's current valuation and future prospects.